Avant BrandsFRA:1BU 35 FCF Margin % is 2.14% as of Feb. 2026. GuruFocus rates FRA:1BU with a GF Score™ of 35/100 and a GF Value™ of €0.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Avant Brands ranks better than 75.16% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avant Brands's Free Cash Flow for the
three
months ended in Feb. 2026 was €0.19 Mil. Avant Brands's Revenue for the
three
months ended in Feb. 2026 was €8.76 Mil. Therefore, Avant Brands's FCF Margin % for the quarter that ended in Feb. 2026 was 2.14%.
The historical rank and industry rank for Avant Brands's FCF Margin % or its related term are showing as below:
FRA:1BU'
s FCF Margin % Range Over the Past 10 Years
Min: -33612.07 Med: -23.05 Max: 15.92
Current: 11.92
During the past 13 years, the highest FCF Margin % of Avant Brands was 15.92%. The lowest was -33612.07%. And the median was -23.05%.
FRA:1BU's FCF Margin % is ranked better than 75.16% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs FRA:1BU: 11.92
Avant Brands FCF Margin % Related Terms
Avant Brands FCF Margin % Historical Data
* Premium members only.
The historical data trend for Avant Brands's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Avant Brands's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avant Brands (FRA:1BU) has a FCF Margin % of 2.14% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avant Brands and its competitors. According to the industry distribution chart, Avant Brands ranks #238 out of 958 companies in the Drug Manufacturers industry, placing it in the top 24.8%.
Is Avant Brands' FCF Margin % too high?
Avant Brands' current FCF Margin % is 2.14%. The Drug Manufacturers industry median FCF Margin % is 2.45. Avant Brands' value of 2.14% is 12.5% below this industry median. Based on the distribution chart, Avant Brands ranks #238 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Avant Brands has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #238 out of 958 companies for FCF Margin %. This places Avant Brands in the top 25% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. Avant Brands' value of 2.14% is 12.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avant Brands's current FCF Margin % of 2.14% is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avant Brands and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avant Brands's current FCF Margin % is 2.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (FRA:1BU) is currently considered Possible Value Trap. The stock's GF Value™ is €0.74, compared to a current price of €0.33 — trading 54.9% below its estimated fair value. The current FCF Margin % is 2.14% and 12.5% below the Drug Manufacturers industry median of 2.45. Avant Brands' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Avant Brands (FRA:1BU), the current FCF Margin % is 2.14% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (FRA:1BU) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of €0.33 is trading 54.9% below its estimated GF Value™ of €0.74.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for FRA:1BU:
FCF Margin %: 2.14%
GF Value™: €0.74 vs. price of €0.33 (54.9% below fair value)
Industry Position: 12.5% below the Drug Manufacturers median (#238 of 958)
No single metric tells the full story. See the FRA:1BU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
35GF Score
Get the complete analysis for FRA:1BU
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1BU has been successfully added to your 
